- Home
- IVVD vs SGA Comparison
IVVD vs SGA Comparison
Compare IVVD & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- SGA
- Stock Information
- Founded
- IVVD 2020
- SGA 1986
- Country
- IVVD United States
- SGA United States
- Employees
- IVVD N/A
- SGA N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- SGA Broadcasting
- Sector
- IVVD Health Care
- SGA Consumer Discretionary
- Exchange
- IVVD Nasdaq
- SGA Nasdaq
- Market Cap
- IVVD 69.0M
- SGA 74.2M
- IPO Year
- IVVD 2021
- SGA 1992
- Fundamental
- Price
- IVVD $0.75
- SGA $12.25
- Analyst Decision
- IVVD Strong Buy
- SGA
- Analyst Count
- IVVD 3
- SGA 0
- Target Price
- IVVD $5.85
- SGA N/A
- AVG Volume (30 Days)
- IVVD 1.8M
- SGA 6.2K
- Earning Date
- IVVD 08-13-2025
- SGA 08-07-2025
- Dividend Yield
- IVVD N/A
- SGA 8.24%
- EPS Growth
- IVVD N/A
- SGA N/A
- EPS
- IVVD N/A
- SGA 0.55
- Revenue
- IVVD $36,688,000.00
- SGA $111,837,000.00
- Revenue This Year
- IVVD $446.60
- SGA N/A
- Revenue Next Year
- IVVD $112.63
- SGA $4.84
- P/E Ratio
- IVVD N/A
- SGA $22.21
- Revenue Growth
- IVVD N/A
- SGA N/A
- 52 Week Low
- IVVD $0.35
- SGA $10.75
- 52 Week High
- IVVD $2.74
- SGA $16.57
- Technical
- Relative Strength Index (RSI)
- IVVD 43.27
- SGA 51.40
- Support Level
- IVVD $0.70
- SGA $12.13
- Resistance Level
- IVVD $1.03
- SGA $12.80
- Average True Range (ATR)
- IVVD 0.07
- SGA 0.44
- MACD
- IVVD -0.03
- SGA -0.05
- Stochastic Oscillator
- IVVD 12.75
- SGA 54.40
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.